The BioEnterics Intragastric Balloon (BIB): How to Use it

Wahlen, C; Bastens, B.; Hervé, Jean-Marie; Malmendier, Claude; Dallemagne, B; Jehaes, C; Markiewicz, S; Monami, B.; Weerts, J

doi:10.1381/096089201321209468

Cited by 47 publications

(22 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A randomized study has shown that a double-channel endoscope was superior to a single-channel endoscope in terms of number of lost balloons, balloon retrieval duration, and patient discomfort (the BIB was seized with both grasping forceps and a snare) [16]. However, in the present author's experience, the use of dedicated ancillary devices to fully empty and then grasp the balloon consistently allows BIB removal, even with a single-channel endoscope [33]. Nonetheless, a double-channel endoscope may be useful because gastric content may be abundant even if a liquid diet has been prescribed for the 24 h preceding BIB removal.…”

Section: Practical Considerationsmentioning

confidence: 65%

“…Balloon removal requires specific material that should be available as soon as a program of BIB therapy is started [33]. A randomized study has shown that a double-channel endoscope was superior to a single-channel endoscope in terms of number of lost balloons, balloon retrieval duration, and patient discomfort (the BIB was seized with both grasping forceps and a snare) [16].…”

Section: Practical Considerationsmentioning

confidence: 99%

See 1 more Smart Citation

Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss

2008

View full text Add to dashboard Cite

We reviewed clinical studies performed with the Bioenterics intragastric balloon (BIB) to promote weight loss. Thirty studies were included [18 prospective (5 randomized), 12 retrospective], totaling 4,877 patients. Only one of three sham-controlled trials found a significantly higher weight loss with the BIB vs the sham procedure plus exhaustive follow-up. In nonrandomized studies, weight loss with the BIB averaged 17.8 kg (range, 4.9-28.5), corresponding to BMI changes of 4.0-9.0 kg/m(2). Comorbidities resolved or improved in 52-100% of patients. Best short-term results were observed in patients devoid of binge eating disorder with a BMI in the 30.0-40.0 kg/m(2) range; the BIB also helped to prepare superobese patients for bariatric surgery. Severe complications were exceptional (gastric perforation and intestinal obstruction; 0.2% each); digestive intolerance prompted early BIB removal in 2.5% of patients. Long-term (>or=2 years) results are awaited, as well as well-designed studies to define the best indications for this therapy.

show abstract

Section: Practical Considerationsmentioning

confidence: 65%

Section: Practical Considerationsmentioning

confidence: 99%

Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss

2008

View full text Add to dashboard Cite

show abstract

“…La implantación del BIB vía endoscópica se realizó en quirófano bajo anestesia general e intubación orotraqueal (16). El BIB fue llenado de forma estándar con 500 cc de suero salino mezclado con 10 ml de azul de metileno para detectar precozmente una fuga mediante la coloración de la orina del paciente (17).…”

Section: Materials Y Métodosunclassified

Efectividad, seguridad y tolerancia del balón intragástrico asociado a una dieta hipocalórica para la reducción de peso en pacientes obesos

Sanchis

Serra

Sorribes

et al. 2008

Rev. esp. enferm. dig.

View full text Add to dashboard Cite

RESUMENIntroducción: la implantación de un balón intragástrico (BI) por vía endoscópica asociado a una dieta hipocalórica es una alternativa en el tratamiento de la obesidad. El objetivo de nuestro estudio es evaluar su efectividad, seguridad y tolerancia.Material y métodos: se incluyen de manera prospectiva 38 pacientes sin contraindicaciones para la implantación del BI, desde marzo de 2004 hasta enero de 2007. La retirada del balón se realizó 6 meses después de la implantación. Evaluamos el peso e índice de masa corporal (IMC) tras la retirada del balón, a los 6 y 12 meses postretirada, así como la tolerancia y aparición de complicaciones durante el tratamiento. Tras la retirada del balón se realizó un cuestionario a cada paciente evaluando la percepción subjetiva al tratamiento.Resultados: después de 6 meses de tratamiento la pérdida de peso media fue de 14,10 kg (0-46) y la reducción media del IMC fue de 5,23 kg/m 2 (0-18). A los 12 meses postretirada del balón el 48,4% de pacientes mantiene o sigue perdiendo peso. Los sín-tomas precoces más frecuentes fueron náuseas (71,1%) y vómitos (57,9%), con buena respuesta a tratamiento sintomático. Presentaron complicaciones 7 pacientes (18,4%): intolerancia digestiva en 4 pacientes, requiriendo retirada precoz del balón en 3 de ellos; esofagitis moderada en 2 pacientes; y perforación gástrica complicada con shock séptico y exitus en 1 paciente. Conclusiones:1. El balón intragástrico asociado a una dieta hipocalórica puede considerarse un tratamiento efectivo, seguro y bien tolerado para el tratamiento de pacientes con obesidad mórbida.2. La pérdida de peso se mantiene en casi la mitad de los pacientes al año tras la retirada del balón.Palabras clave: Obesidad. Obesidad mórbida. Balón intragástri-co. Endoscopia. ABSTRACTIntroduction: the endoscopic placement of an intragastric balloon (IGB) in association with a low-calorie diet is an option for the treatment of obesity. The aim of the present study was to evaluate its effectiveness, safety, and tolerance.Material and methods: thirty-eight patients with no contraindications for IGB were included in this prospective study from March 2004 to January 2007. Balloon removal was performed 6 months later. Weight and body mass index (BMI) were evaluated after IGB removal and at 6 months and 1 year thereafter. Tolerance and complications during treatment were evaluated. Patients filled out a questionnaire to evaluate their subjective perception of treatment.Results: mean weight loss after 6 months on balloon treatment was 14.10 kg (0-46), and mean BMI reduction was 5.23 kg/m2 (0-18). At 12 months after balloon removal 48.4% of patients maintained their weight loss or kept loosing weight. Most common early symptoms included nausea (71.1%) and vomiting (57.9%) with a good response to symptomatic treatment. Complications were seen in 7 patients (18.4%): digestive intolerance in 4 patients, with early removal in 3 of them; moderate esophagitis in 2 patients; and gastric perforation complicated with septic shock and death in 1 pat...

show abstract

“…Whether managed by diets, exercise and medication, or endoscopic and surgical interventions, the treatment of obesity aims to reduce weight and the risks of comorbidities [2]. Temporary intragastric balloon application together with a diet program has gained popularity [3,4]. This clinical prospective study has been designed to evaluate the effects of intragastric balloon application on obese patients.…”

Section: Introductionmentioning

confidence: 99%